El-Hibri Fuad

CIK 00013801852 companiesGAITHERSBURG, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001380185

Recent Transactions

50 trades

Other
Aptevo Therapeutics Inc.$APVO
Common Stock
2021-12-03+7,373→ 7,373 total
Other
Emergent BioSolutions Inc.$EBS
Common Stock
2021-12-03+206,434→ 206,434 total
Other
Emergent BioSolutions Inc.$EBS
Common Stock
2021-12-03+274,930→ 274,930 total
Other
Aptevo Therapeutics Inc.$APVO
Common Stock
2021-12-03+107,807→ 107,807 total
Other
Emergent BioSolutions Inc.$EBS
Common Stock
2021-12-03+3,018,644→ 3,018,644 total
Other
Aptevo Therapeutics Inc.$APVO
Common Stock
2021-12-03+9,819→ 9,819 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2021-06-01+893→ 893 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2021-06-01+2,678→ 2,678 total
Award
Emergent BioSolutions Inc.$EBS
Restricted Stock Unit
2021-02-24+13,906→ 13,906 total
Award
Emergent BioSolutions Inc.$EBS
Employee Stock Options (Right to Buy)
2021-02-24+27,808→ 27,808 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Stock Options (Right to Buy)
2020-11-10−19,391→ 0 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-10$88.21/sh−19,391→ 1,123,988 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-10$26.45/sh+19,391→ 1,143,379 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-09$95.26/sh−20,000→ 1,123,988 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-09$26.45/sh+20,000→ 1,143,988 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Stock Options (Right to Buy)
2020-11-09−20,000→ 19,391 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Stock Options (Right to Buy)
2020-11-03−20,000→ 39,391 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-03$26.45/sh+20,000→ 1,143,988 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-03$90.74/sh−20,000→ 1,123,988 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-02$90.44/sh−20,000→ 1,123,988 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2020-11-02$26.45/sh+20,000→ 1,143,988 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Stock Options (Right to Buy)
2020-11-02−20,000→ 59,391 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-09-24$98.85/sh−12,535→ 1,123,988 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-09-23$100.58/sh−13,000→ 1,136,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-09-17$100.68/sh−20,000→ 1,149,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-09-16$102.48/sh−20,000→ 1,169,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-09-10$102.66/sh−20,000→ 1,189,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-09-09$102.80/sh−20,000→ 1,209,523 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−1,339→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+1,322→ 1,322 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−1,785→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−892→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+170→ 170 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-02+3,571→ 3,571 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-30$74.01/sh−20,000→ 1,229,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-29$74.24/sh−20,000→ 1,249,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-23$68.49/sh−20,000→ 1,269,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-22$66.81/sh−20,000→ 1,289,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-16$62.47/sh−20,000→ 1,309,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-15$62.58/sh−12,537→ 1,329,523 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-14$62.99/sh−6,261→ 1,342,060 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-13$62.25/sh−17,071→ 1,348,321 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-09$61.83/sh−23,716→ 1,365,392 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-08$60.75/sh−13,000→ 1,413,470 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-08$61.34/sh−24,362→ 1,389,108 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-07$60.76/sh−14,336→ 1,426,470 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-04-06$60.50/sh−28,240→ 1,440,806 total
Exercise/Conversion
Emergent BioSolutions Inc.$EBS
Common Stock
2020-02-27+9,794→ 1,482,737 total
Tax Payment
Emergent BioSolutions Inc.$EBS
Common Stock
2020-02-27$58.42/sh−3,854→ 1,478,883 total
Sale
Emergent BioSolutions Inc.$EBS
Common Stock
2020-02-27$56.97/sh−9,837→ 1,469,046 total

Companies

Recent Filings

Address

400 PROFESSIONAL DRIVE, SUITE 400

GAITHERSBURG, MD, 20879

View on SEC.gov